58 results
Page 2 of 3
8-K
EX-99.1
q9pk 1x07
1 Jun 21
Results of Operations and Financial Condition
7:36am
8-K
EX-99.1
00m h879v
2 Feb 21
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
6:52am
424B3
c4nuja
12 Nov 20
Prospectus supplement
8:32am
424B4
u0n0rbgvtjc50nn
3 Sep 20
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
xvinn6o6mv4t
25 Aug 20
Regulation FD Disclosure
9:07am
DRS
g8pe17r ojn2c0
19 Aug 20
Draft registration statement
12:00am
424B3
0tmwz
12 Aug 20
Prospectus supplement
4:28pm
DEF 14A
jej7pma8 g9s5esmxo
9 Jul 20
Definitive proxy
4:08pm
424B3
052g9ixu
29 Jun 20
Prospectus supplement
8:39am
10-K
141edsrz
29 Jun 20
Annual report
8:30am
424B4
6ijjiua xax
14 Apr 20
Prospectus supplement with pricing info
5:27pm
424B3
177xk
10 Apr 20
Prospectus supplement
6:09am
DRS
bd5j8a
1 Apr 20
Draft registration statement
12:00am